c="Autoimmune lymphoproliferative syndrome" 1:0 1:2||t="problem"||cui="C1328840"||tot="AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME"||ns="-1000"
c="Autoimmune lymphoproliferative syndrome (ALPS" 2:0 2:3||t="problem"||cui="C1328840"||tot="AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME"||ns="-1000"
c="immunological tolerance" 2:11 2:12||t="problem"||cui="C0013220"||tot="Drug Tolerance"||ns="-861"
c="APT1 gene" 2:21 2:22||t="test"||cui="C0017337"||tot="Genes"||ns="-861"
c="APO-1" 2:27 2:27||t="test"||cui="C1539477"||tot="FAS gene"||ns="-1000"
c="African American alleles" 2:152 2:154||t="test"||cui="C0002085"||tot="Alleles"||ns="-827"
c="Among the ALPS-associated Fas mutants" 2:155 2:159||t="problem"||cui="C0596988"||tot="Mutant"||ns="-766"
c="mutants" 2:169 2:169||t="problem"||cui="C0596988"||tot="Mutant"||ns="-966"
c="ALPS phenotype" 2:195 2:196||t="problem"||cui="C0031437"||tot="Phenotype"||ns="-812"
